Kiora Pharmaceuticals
PublicKiora Pharmaceuticals is now publicly traded
The data on this page reflects Kiora Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Apr 21, 2026
Total Funding Raised
$20M
Company Overview
Kiora Pharmaceuticals is a clinical-stage biopharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases.
AI Layer
Non-AI
Keywords
Kiora Pharmaceuticals Comparables
Compare Kiora Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanoscope Therapeutics Inc. | 82% | |
| Ray Therapeutics | 79% | |
| Restore Vision Inc. | 76% |
Kiora Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Apr 21, 2026 | ||||
| Private Placement | Feb 14, 2024 |
Key People
Founding team and executive leadership
Kiora Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ADAR1 Capital Management | Private Placement |
| Velan Capital | Private Placement |
| Perceptive Advisors | Private Placement |
| Rosalind Advisors | Private Placement |
| Stonepine Capital Management | Private Placement |
| Nantahala Capital Management | Private Placement |
Kiora Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access